The therapeutic implications of the genomic analysis of malignant pleural mesothelioma Editorial
| Author: | Zauderer, M. G. |
| Title: | The therapeutic implications of the genomic analysis of malignant pleural mesothelioma |
| Keywords: | treatment response; gene mutation; genetics; missense mutation; mutation; bevacizumab; cisplatin; drug approval; note; antineoplastic agent; biological marker; genetic predisposition to disease; ipilimumab; antineoplastic combined chemotherapy protocols; lung neoplasms; practice guideline; food and drug administration; protein p53; lung tumor; tumor suppressor gene; pleura mesothelioma; mesothelioma; genomics; pleura tumor; metastasis potential; genetic predisposition; pemetrexed; protein kinase; pleural neoplasms; phase 2 clinical trial (topic); phase 1 clinical trial (topic); procedures; nivolumab; rucaparib; humans; human; rna sequencing; pegargiminase; tazemetostat; oncogenomics; malignant neoplasm; larotrectinib |
| Journal Title: | Nature Communications |
| Volume: | 12 |
| ISSN: | 2041-1723 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2021-03-22 |
| Start Page: | 1819 |
| Language: | English |
| DOI: | 10.1038/s41467-021-22142-y |
| PUBMED: | 33753750 |
| PROVIDER: | scopus |
| PMCID: | PMC7985484 |
| DOI/URL: | |
| Notes: | Note -- Export Date: 3 May 2021 -- Source: Scopus |
